Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002007634 | SCV002260217 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2023-08-08 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This sequence change affects a splice site in intron 4 of the MCCC2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MCCC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1474479). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Revvity Omics, |
RCV002007634 | SCV003833921 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2022-02-24 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002007634 | SCV004194372 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2023-05-04 | criteria provided, single submitter | clinical testing |